Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project)-Reference-Cited by-同舟云学术

Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project)

Published:2017-04-12 Issue:4 Volume:51 Page:269-276
ISSN:2168-1805
Container-title:Scandinavian Journal of Urology
language:en
Short-container-title:Scandinavian Journal of Urology

Author:

May Matthias¹,Surcel Cristian²,Capitanio Umberto³,Dell’Oglio Paolo³,Klatte Tobias⁴,Shariat Shahrokh⁴,Ecke Thorsten⁵,Wolff Ingmar⁶,Vergho Daniel⁷,Wagener Nina⁸,Huck Nina⁸,Pahernik Sascha⁹,Zastrow Stefan¹⁰,Wirth Manfred¹⁰,Borgmann Hendrik¹¹,Haferkamp Axel¹¹,Musquera Mireia¹²,Krabbe Laura M.¹³,Herrmann Edwin¹³,Scavuzzo Anna¹⁴,Mirvald Cristian²,Hutterer Georg¹⁵,Zigeuner Richard¹⁵,Stief Christian G.¹⁶,Waidelich Raphaela¹⁶,Cindolo Luca¹⁷,Kalusova Krystina¹⁸,Brookman-May Sabine D.¹⁶,

Affiliation:

1. Department of Urology, Klinikum St. Elisabeth Straubing, Straubing, Germany;

2. Centre of Urological Surgery, Dialysis and Renal Transplantation, Fundeni Clinical Institute, Bucharest, Romania;

3. Department of Urology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy;

4. Department of Urology, Medical University of Vienna, Vienna, Austria;

5. Department of Urology, Hospital Bad Saarow, Bad Saarow, Germany;

6. Department of Urology, Carl-Thiem-Klinikum Cottbus, Cottbus, Germany;

7. Department of Urology and Paediatric Urology, Julius-Maximilians-University Medical Centre of Wuerzburg, Wuerzburg, Germany;

8. Department of Urology, University Hospital Mannheim, Mannheim, Germany;

9. Department of Urology, Klinikum Nürnberg, Nürnberg, Germany;

10. Department of Urology, Carl Gustav Carus University Dresden, University Hospital, Germany;

11. Department of Urology, University Hospital Mainz, Mainz, Germany;

12. Department of Nephrology and Urology, University of Barcelona, Barcelona, Spain;

13. Department of Urology, University of Muenster Medical Center, Muenster, Germany;

14. Department of Urology, Instituto Nacional de Cancerologia-INCan, Mexico City, Mexico;

15. Department of Urology, Medical University Graz, Graz, Austria;

16. Department of Urology, Ludwig-Maximilians University, Campus Grosshadern, Munich, Germany;

17. Department of Urology, Pio Da Pietrelcina Hospital, Vasto, Italy;

18. Department of Urology, Faculty of Medicine, Charles University, Pilsen, Czech Republic

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21681805.2017.1300187

Reference17 articles.

1. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia

2. Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association

3. Impact of Histologic Subtype on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus

4. Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma – A multicentre study

5. Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Papillary Renal Cell Carcinoma With Microcystic Architecture Is Strongly Associated With Extrarenal Invasion and Metastatic Disease;American Journal of Surgical Pathology;2021-09-09

2. Overexpressed sFRP3 exerts an inhibitory effect on hepatocellular carcinoma via inactivation of the Wnt/β-catenin signaling pathway;Cancer Gene Therapy;2020-09-26

3. Expression and clinical value of SALL4 in renal cell carcinomas;Molecular Medicine Reports;2020-05-22

4. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway;Cellular Signalling;2019-04

5. Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis;BMC Cancer;2018-09-03